{"id":11091,"date":"2023-04-24T00:00:00","date_gmt":"2023-04-24T04:00:00","guid":{"rendered":"https:\/\/livingstagenew.wpenginepowered.com\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/"},"modified":"2026-07-27T10:49:32","modified_gmt":"2026-07-27T14:49:32","slug":"livingstone-advises-neoplas-meds-series-b-financing-round","status":"publish","type":"transaction","link":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","title":{"rendered":"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung"},"content":{"rendered":"\n<p><strong>Das D\u00fcsseldorfer Healthcare-Team von Livingstone hat die <\/strong><a href=\"https:\/\/neoplas-med.eu\/\"><strong>neoplas med GmbH<\/strong><\/a><strong> auch in ihrer zweiten Finanzierungsrunde beraten. <\/strong><a href=\"https:\/\/niterra.de\/\"><strong>Niterra<\/strong><\/a><strong> (vormals NGK Spark Plug Co., LTD) baut seine Partnerschaft mit dem Medizintechnik-Unternehmen durch eine Wachstumsinvestition in partnerschaftlicher Zusammenarbeit mit <\/strong><a href=\"https:\/\/www.pegasustechventures.com\/\"><strong>Pegasus Technology Ventures<\/strong><\/a><strong> aus. Ziel des Investments ist es, die Internationalisierung der neoplas med aus Greifswald weiter zu unterst\u00fctzen und die Entwicklung neuer Produkte und Anwendungen der Kaltplasma Technologie voranzutreiben.<\/strong><\/p>\n<p>Im Juni 2022 begleitete Livingstone die neoplas med GmbH bereits bei der ersten Finanzierungsrunde und konnte den japanischen Technologiekonzern NGK Spark Plug, der seit April 2023 unter Niterra firmiert, als strategischen Partner gewinnen. neoplas med hat eine Therapie zur Behandlung von chronischen und infizierten Wunden entwickelt, bei der Kaltplasma ber\u00fchrungslos und unter Sichtkontrolle weitestgehend schmerzfrei auf Wunden aufgetragen wird. Das Kaltplasma aus dem <a href=\"https:\/\/neoplas-med.eu\/produkt\/\">kINPen<sup>\u00ae<\/sup> MED<\/a> t\u00f6tet Keime und Erreger ab und regt die Mikrozirkulation sowie die Neovaskularisation und Zellproliferation an.<\/p>\n<p>Niterra ist ein japanischer Technologiekonzern, der sich seit seiner Gr\u00fcndung auf Z\u00fcndkerzen, Sensortechnik und technische Keramik spezialisiert hat. Die medizinische Abteilung des Unternehmens entwickelt Technologien in den Bereichen Atemwegserkrankungen, Frauengesundheit, h\u00e4usliche Pflege und Kaltplasma. Mit einer Bilanzsumme von mehr als 1 Milliarde Dollar und einem in Partnerschaft mit Pegasus Tech Ventures eingerichteten Risikokapitalfonds in H\u00f6he von 100 Millionen Dollar investiert das Unternehmen weltweit in Spitzentechnologien, einschlie\u00dflich medizinischer Ger\u00e4te.<\/p>\n<p><em>&#8220;Wir haben unseren Umsatz im Jahr 2022 verdoppelt und danken unserem strategischen Partner Niterra f\u00fcr das Vertrauen und die Unterst\u00fctzung bei der Internationalisierung und der Erschlie\u00dfung neuer Vertriebskan\u00e4le. Wir sind stolz auf das starke Ergebnis und darauf, dass Niterra sein strategisches Investment weiter ausbaut. Das sind wichtige Meilensteine auf unserer Reise, die bahnbrechende Plasmajet-Technologie weltweit zug\u00e4nglich zu machen und weiterzuentwickeln&#8221;, <\/em>sagt <strong>Ulrike Sailer<\/strong>, Gesch\u00e4ftsf\u00fchrerin der neoplas med GmbH.<\/p>\n<p><em>&#8220;Die neoplas med und ihre Beachtung in der medizinischen Fachwelt waren von Anfang an interessant f\u00fcr uns. Unter der Leitung von Ulrike Sailer hat sich das Unternehmen sehr gut entwickelt und ich freue mich sehr \u00fcber das Potenzial, weiter zu wachsen und zu expandieren&#8221;<\/em>, so <strong>Dirk Schapeler<\/strong>, Gesch\u00e4ftsf\u00fchrer von Niterra Ventures. Im Rahmen der Kapitalerh\u00f6hung bauen die Unternehmen ihre strategische Partnerschaft weiter aus.<\/p>\n<p><a href=\"https:\/\/livingstonepartners.com\/de\/team\/dr-ralf-nowak\/\"><strong>Dr. Ralf Nowak<\/strong><\/a>, Partner bei Livingstone in D\u00fcsseldorf kommentiert: <em>\u201eWir freuen uns sehr, neoplas med bei dem Weg von einem Start-Up zu einem dynamischen Technologieunternehmen begleiten zu k\u00f6nnen. Niterra ist ein idealer Partner f\u00fcr neoplas med, der den weiteren Weg der Internationalisierung und der Verbreiterung der Produktbasis sowie der Anwendungsfelder unterst\u00fctzt.\u201c<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Das D\u00fcsseldorfer Healthcare-Team von Livingstone hat die neoplas med GmbH auch in ihrer zweiten Finanzierungsrunde beraten.<\/p>\n","protected":false},"featured_media":3863,"template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"client-type":[],"region":[],"sector":[],"service":[],"transaction-type":[],"class_list":["post-11091","transaction","type-transaction","status-publish","has-post-thumbnail","hentry"],"acf":{"team_members":[1332,1360],"date":"20230424","client_type":43,"type":[1050],"region":[379,385,1185],"services":[],"sectors":[693,702],"related_transactions":[11072,10913,10780,10688],"related_testimonials":"","contacts":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung - Livingstone Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung\" \/>\n<meta property=\"og:description\" content=\"Das D\u00fcsseldorfer Healthcare-Team von Livingstone hat die neoplas med GmbH auch in ihrer zweiten Finanzierungsrunde beraten.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Livingstone Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-27T14:49:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png\" \/>\n\t<meta property=\"og:image:width\" content=\"550\" \/>\n\t<meta property=\"og:image:height\" content=\"370\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/\",\"name\":\"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung - Livingstone Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/18343c2a.png\",\"datePublished\":\"2023-04-24T04:00:00+00:00\",\"dateModified\":\"2026-07-27T14:49:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#primaryimage\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/18343c2a.png\",\"contentUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/18343c2a.png\",\"width\":550,\"height\":370},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/livingstone-advises-neoplas-meds-series-b-financing-round\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Homepage\",\"item\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions\",\"item\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/transaction\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/\",\"name\":\"Livingstone Partners\",\"description\":\"Deals Done Right.\",\"publisher\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/#organization\",\"name\":\"Livingstone Partners\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo_livingstone.svg\",\"contentUrl\":\"https:\\\/\\\/livingstonepartners.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/logo_livingstone.svg\",\"caption\":\"Livingstone Partners\"},\"image\":{\"@id\":\"https:\\\/\\\/livingstonepartners.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/livingstone\\\/\"],\"description\":\"Livingstone is an independent, global M&A and debt advisory firm with a proven track record of delivering exceptional outcomes for private and public businesses and private equity investors.\",\"email\":\"marketing@livingstonepartners.com\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung - Livingstone Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","og_locale":"de_DE","og_type":"article","og_title":"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung","og_description":"Das D\u00fcsseldorfer Healthcare-Team von Livingstone hat die neoplas med GmbH auch in ihrer zweiten Finanzierungsrunde beraten.","og_url":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","og_site_name":"Livingstone Partners","article_modified_time":"2026-07-27T14:49:32+00:00","og_image":[{"width":550,"height":370,"url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","url":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/","name":"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung - Livingstone Partners","isPartOf":{"@id":"https:\/\/livingstonepartners.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#primaryimage"},"image":{"@id":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#primaryimage"},"thumbnailUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","datePublished":"2023-04-24T04:00:00+00:00","dateModified":"2026-07-27T14:49:32+00:00","breadcrumb":{"@id":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#primaryimage","url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","contentUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/18343c2a.png","width":550,"height":370},{"@type":"BreadcrumbList","@id":"https:\/\/livingstonepartners.com\/de\/transaction\/livingstone-advises-neoplas-meds-series-b-financing-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/livingstonepartners.com\/de\/"},{"@type":"ListItem","position":2,"name":"Transactions","item":"https:\/\/livingstonepartners.com\/de\/transaction\/"},{"@type":"ListItem","position":3,"name":"Livingstone ber\u00e4t neoplas med auch bei der Series B Finanzierung"}]},{"@type":"WebSite","@id":"https:\/\/livingstonepartners.com\/de\/#website","url":"https:\/\/livingstonepartners.com\/de\/","name":"Livingstone Partners","description":"Deals Done Right.","publisher":{"@id":"https:\/\/livingstonepartners.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/livingstonepartners.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/livingstonepartners.com\/de\/#organization","name":"Livingstone Partners","url":"https:\/\/livingstonepartners.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/livingstonepartners.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/logo_livingstone.svg","contentUrl":"https:\/\/livingstonepartners.com\/wp-content\/uploads\/2026\/05\/logo_livingstone.svg","caption":"Livingstone Partners"},"image":{"@id":"https:\/\/livingstonepartners.com\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/livingstone\/"],"description":"Livingstone is an independent, global M&A and debt advisory firm with a proven track record of delivering exceptional outcomes for private and public businesses and private equity investors.","email":"marketing@livingstonepartners.com"}]}},"_links":{"self":[{"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction\/11091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction"}],"about":[{"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/types\/transaction"}],"version-history":[{"count":2,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction\/11091\/revisions"}],"predecessor-version":[{"id":89419,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction\/11091\/revisions\/89419"}],"acf:post":[{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction\/10688"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction\/10780"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction\/10913"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction\/11072"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/team-member\/1360"},{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/team-member\/1332"}],"acf:term":[{"embeddable":true,"taxonomy":"sector","href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/sector\/702"},{"embeddable":true,"taxonomy":"sector","href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/sector\/693"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/region\/1185"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/region\/385"},{"embeddable":true,"taxonomy":"region","href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/region\/379"},{"embeddable":true,"taxonomy":"transaction-type","href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction-type\/1050"},{"embeddable":true,"taxonomy":"client-type","href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/client-type\/43"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/media\/3863"}],"wp:attachment":[{"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/media?parent=11091"}],"wp:term":[{"taxonomy":"client-type","embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/client-type?post=11091"},{"taxonomy":"region","embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/region?post=11091"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/sector?post=11091"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/service?post=11091"},{"taxonomy":"transaction-type","embeddable":true,"href":"https:\/\/livingstonepartners.com\/de\/wp-json\/wp\/v2\/transaction-type?post=11091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}